title: The difference between platelet and plasma FXIII used to study the mechanism of platelet microvesicle formation.
abstract: The formation of microvesicles from platelets was induced either by activation of the complement system by a monoclonal antibody to CD9, or by incubation of platelets with the calcium ionophore A23187. A filter technique to isolate the microvesicles without plasma contamination is described. The microvesicles contained FXIIIa2 from the platelet cytoplasm which shows that these particles contain significant amounts of intracellular material. This was shown by the use of crossed immunoelectrophoresis with rabbit antibodies to total human platelet proteins in the second dimension gel and polyclonal antibodies against the a- and b-subunit of FXIII in the intermediate gel. The FXIIIa2 in the microvesicle was found to be functional as an enzyme. To prove this, it was shown that FXIII in its immunoprecipitate arc could catalyze the incorporation of monodansylcadaverine into casein as identified by fluorescence of this arc in ultraviolet light. The observation that the plasma form of FXIII (FXIIIa2b2) was absent from the microvesicles collected by the filtration technique, whereas it was present in platelet fragments obtained by mechanical disruption by ultrasonication, indicates that the activation-dependent microvesicles are formed by a true budding process with the inclusion of intracellular, but not extracellular material.
authors.affiliation: Research Institute for Internal Medicine, Rikshospitalet, University of Oslo, Norway.
authors.forename: P A
authors.initials: PA
authors.lastname: Holme
authors.forename: F
authors.initials: F
authors.lastname: Brosstad
authors.forename: N O
authors.initials: NO
authors.lastname: Solum
mesh_terms: D000911:Antibodies, Monoclonal; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure; D000001:Calcimycin / Q000494:pharmacology; D002118:Calcium / Q000502:physiology; D003167:Complement Activation / Q000502:physiology; D005176:Factor XIII / Q000378:metabolism*; D006801:Humans; D008970:Molecular Weight; D011233:Precipitin Tests; D013438:Sulfhydryl Compounds / Q000032:analysis
chemical_list: D000911:Antibodies, Monoclonal; D013438:Sulfhydryl Compounds; D000001:Calcimycin; D005176:Factor XIII; D002118:Calcium